Senior Analyst
Nina CapitalCheck size: Nina Capital does not publish one standard current check-size range on its official site.
Fiorela Kapllanaj invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a need-driven, value-based Biodesign approach..
Deeply understood healthcare needs, evidence of stakeholder value, thoughtful teams and technology capable of international impact.
Technology in search of a healthcare need, weak clinical or economic value, and companies outside the published geographies are less aligned.
Lead with the unmet need, stakeholders, evidence, workflow and economic value, regulatory path, team and the milestone to Series A readiness.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Fiorela Kapllanaj is a current Senior Analyst at Nina Capital, according to the firm's official roster. No additional biography is inferred where the official source does not publish one.